Current status and practical use of effluent biomarkers in peritoneal dialysis patients

American Journal of Kidney Diseases

Volumn 62, Issue 4, 2013, Pages 823-833

  Lopes Barreto, Deirisa ^a   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

biomarkers; fibrosis; inflammation; mesothelial cells; Peritoneal dialysis; peritoneal membrane

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; CA 125 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; DIALYSIS FLUID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; ALPORT SYNDROME; ARTICLE; BASEMENT MEMBRANE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; EFFLUENT; ENDOTHELIAL DYSFUNCTION; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INTESTINE OBSTRUCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROTOMY; MALE; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; PERMEABILITY; PROTEIN BLOOD LEVEL; STAPHYLOCOCCUS AUREUS;

BIOMARKERS; FIBROSIS; INFLAMMATION; MESOTHELIAL CELLS; PERITONEAL DIALYSIS; PERITONEAL MEMBRANE;

ADULT; BIOLOGICAL MARKERS; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; PERITONEAL DIALYSIS;

EID: 84884534585     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.01.031     Document Type: Article

References (96)

1. T.L. Nickolas, J. Barash, P. Devarajan Biomarkers in acute and chronic kidney disease Curr Opin Nephrol Hypertens 17 2 2008 127 132
2. J.T. Dulaney, F.E. Hatch Peritoneal dialysis and loss of proteins: a review Kidney Int 26 3 1984 253 262
3. D.E. Sampimon, A.M. Coester, D.G. Struijk, R.T. Krediet The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis Nephrol Dial Transplant 26 1 2011 291 298
4. M.A. Mateijsen, A.C. van der Wal, P.M. Hendriks Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis Perit Dial Int 19 6 1999 517 525
5. M.M. Zweers, R.T. Krediet, D.G. Stuijk Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat Nephrol Dial Nephrol 16 3 2001 651 654
6. J.D. Williams, K.J. Craig, N. Topley Morphologic changes in the peritoneal membrane of patients with renal disease J Am Soc Nephrol 13 2 2002 470 479
7. K. Honda, H. Oda Pathology of encapsulating peritoneal sclerosis Perit Dial Int 20 suppl 4 2000 S19 S29
8. G. Del Peso, J.A. Jiménez-Hefferman, M.A. Bajo Epithelial-to-mesenchymal transition of mesothelial cells is an early event during peritoneal dialysis and is associated with high peritoneal transport Kidney Int 73 2008 S26 S33
9. M.A. Friedlander, Y.C. Wu, J.A. Schulak, V.M. Monnier, D.E. Hriicik Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease Am J Kidney Dis 25 3 1995 445 451
10. S. Combet, T. Miyata, P. Moulin, D. Pouthier, E. Goffin, O. Devuyst Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis J Am Soc Nephrol 11 4 2000 717 728
11. M.M. Zweers, P.J. Margetts Animal models for peritoneal dialysis R. Khanna, R.T. Krediet, Nolph and Gokals's Textbook of Peritoneal Dialysis 3rd ed. 2009 Springer Science & Business Media New York, NY 181 192
12. A.M. Coester, W. Smit, D.G. Struijk Peritoneal functions in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function NDT Plus. 2 2 2009 104 110
13. R.T. Krediet, D.G. Struijk Peritoneal membrane evaluation in clinical practice Contrib Nephrol. 178 2012 232 237
14. C.E. Douma, D.R. de Waart, D.G. Struijk, R.T. Krediet The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD Kidney Int 51 1997 1885 1892
15. D. Zemel, A.L.T. Imholz, D.R. de Waart, C. Dinkla, D.G. Struijk, R.T. Krediet Appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent of CAPD Kidney Int 46 1994 1422 1430
16. R.T. Krediet, D.E. Sampimon, A. Vlijm, A.M. Coester, D.G. Struijk, W. Smit Biological markers in the peritoneal dialysate effluent: are they useful Contrib Nephrol 163 2009 54 59
17. M.M. Pannekeet, D. Zemel, G.C. Koomen, D.G. Struijk, R.T. Krediet Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD Perit Dial Int 15 6 1995 217 225
18. D. Zemel, R.T. Krediet, G.C. Koomen, W.M. Kortekaas, H.G. Geertzen, R.J. ten Berge Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation Nephrol Dial Transplant 9 2 1994 169 174
19. D. Zemel, D.G. Struijk, C. Dinkla, L.M. Stolk, I.J. ten Berge, R.T. Krediet Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis J Lab Clin Med 126 2 1995 204 215
20. T. Sitter, M. Spannagl, H. Schiffl, E. Held, V.W. van Hinsbergh, T. Kooistra Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells Nephrol Dial Transplant 10 5 1995 677 683
21. S. Yung, G.A. Coles, J.D. Williams, M. Davies The source and possible significance of hyaluronan in the peritoneal cavity Kidney Int 46 194 1994 527 533
22. T. Sakurada, S. Kojima, D. Oishi Prothrombin fragment 1+2 (F1+2) in effluent is a useful marker for peritoneal permeability in peritoneal dialysis patients using neutral dialysate Adv Perit Dial 27 2011 2 5
23. M. Goedde, T. Sitter, H. Schiffl, U. Bechtel, W. Schramm, M. Spannagl Coagulation and fibrinolysis-related antigens in plasma and dialysate of CAPD patients Perit Dial Int 17 2 1997 162 166
24. A.W. De Boer, M. Levi, R.E. Reddingins Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis Paediatr Nephrol 13 4 1999 284 287
25. R.F. Buckman, M. Woods, L. Sargent, A.S. Gervin A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions J Surg Res 20 1 1976 1 5
26. M.N. Vipond, S.A. Whawell, H.A.F. Dudley, J.N. Thompson Peritoneal fibrinolytic activity and intra-abdominal adhesions Lancet 335 8698 1990 1120 1122
27. D. Lopes Barreto, A.M. Coester, M. Noordzij Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients Nephrol Dial Transplant 26 11 2011 3739 3744
28. R. Pecoits-Filho, M.R. Araújo, B. Lindholm Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate Nephrol Dial Transplant 17 8 2002 1480 1486
29. D. Zemel, I.J.M. ten Berge, D.G. Struijk, E. Bloemena, G.C.M. Koomen, R.T. Krediet Interleukin-6 in CAPD patients without peritonitis: relationship to the intrinsic permeability of the peritoneal membrane Clin Nephrol 37 2 1992 97 103
30. A.S. Rodrigues, M. Almeida, I. Fonseca Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation Nephrol Dial Transplant 21 3 2006 763 769
31. S. van Esch, M.M. Zweers, M.A. Jansen Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients Perit Dial Int 24 6 2004 554 561
32. R. Pecoits-Filho, M.J. Carvalho, P. Stenvinkel, B. Lindholm, O. Heimbürger Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis Perit Dial Int 26 1 2006 53 63
33. A.S. Rodrigues, M. Martins, J.C. Korevaar Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters Am J Nephrol 27 1 2007 84 91
34. L.A. Cooker, P. Luneburg, C.J. Holmes, S. Jones, N. Topley Bicarbonate/Lactate Study Group Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions Perit Dial Int 21 suppl 3 2001 S102 S107
35. L. Weiss, B. Stegmayr, G. Malmsten Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution Perit Dial Int 29 6 2009 647 655
36. S. Opatrna, D. Lysak, L. Trefil, C. Parker, N. Topley Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions Perit Dial Int 32 1 2012 37 44
37. J.D. Williams, N. Topley, K.J. Craig The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane Kidney Int 66 1 2004 408 418
38. M. Mizutani, Y. Ito, M. Mizuno Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate Am J Physiol Renal Physiol 298 3 2010 F721 F733
39. R.T. Krediet, I.E. Blom, M.M. Zweers Connective tissue growth factor (CTGF) is associated with peritoneal transport parameters [ISPD abstract] Perit Dial Int 26 suppl 2 2006 S8
40. M.M. Zweers, D.R. de Waart, W. Smit, D.G. Struijk, R.T. Krediet The growth factors VEGF and TGF-beta1 in peritoneal dialysis J Lab Clin Med 134 2 1999 124 132
41. P.J. Margetts, M. Kolb, T. Galt, C.M. Hoff, T.R. Shockley, J. Gauldie Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function J Am Soc Nephrol 12 10 2001 2029 2039
42. S. Jones, C.J. Holmes, R.T. Krediet Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels Kidney Int 59 4 2001 1529 1538
43. M.M. Zweers, D.G. Struijk, W. Smit, R.T. Krediet Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up J Lab Clin Med 137 2 2001 125 132
44. D.E. Sampimon, M.R. Korte, D. Lopes Barreto Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study Perit Dial Int 30 2 2010 161 169
45. S. Ahmad, B.V. North, A. Qureshi CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis Eur J Clin Invest 40 12 2010 1067 1073
46. K.N. Lai, C.C. Szeto, K.B. Lai, C.W.K. Lam, D.T.M. Chan, J.C.K. Leung Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD Am J Kidney Dis 33 2 1999 318 324
47. K. Yamagata, C. Tomida, A. Koyama Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients Perit Dial Int 19 2 1999 131 137
48. C.C. Szeto, T.Y.H. Wong, K.B. Lai, C.W.K. Lam, K.L. Lai, P.K.T. Li Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis Am J Kidney Dis 36 3 2000 609 614
49. I. Hirahara, M. Inoue, T. Umino, O. Saito, S. Muto, E. Kusano Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan Nephrol Dial Transplant 26 5 2011 1695 1701
50. D. Lopes Barreto, A.M. Coester, D.G. Struijk, R.T. Krediet Can effluent matrix metalloproteinase-2 and plasminogen activator inhibitor-1 be used as biomarkers of peritoneal membrane alterations in peritoneal dialysis patients? Perit Dial Int 2013 In press
51. F. Perfumo, P. Altieri, M.L. Degl'Innocenti Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation Nephrol Dial Transplant 11 9 1996 1803 1809
52. B. Rippe, O. Simonsen, O. Heimbürger Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products Kidney Int 59 1 2001 348 357
53. C.C. Szeto, K.M. Chow, C.W. Lam Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose degradation products: a 1-year randomized control trial Nephrol Dial Transplant 22 2 2007 552-539
54. S. Haas, C.P. Schmitt, K. Arbeiter Improved acidosis correction and recovery of mesothelial cell mass with neutral pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis J Am Soc Nephrol 14 10 2003 2632 2638
55. C.Y. Le Poole, A.G. Welten, M.C. Weijmer, R.M. Valentijn, F.J. van Ittersum, P.M. ter Wee Initiating CAPD with a regimen low in glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious Perit Dial Int 25 suppl 3 2005 S64 S68
56. R.T. Krediet Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Perit Dial Int 21 6 2001 560 567
57. V.R. Zurawski, H. Orjaseter, A. Anderson, E. Jellum Elevated serum CA125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer Int J Cancer 42 5 1988 677 680
58. G.J. Bon, P. Kenemans, R. Verstraeten, G.J. van Kamp, J. Hilgers Serum tumor marker immunoassays in gynecologic oncology: establishment of reference values Am J Obstet Gynecol 174 1 1996 107 114
59. C.E. Visser, J.J.E. Brouwer-Steenbergen, M.G.H. Betjes Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients Nephrol Dial Transplant 10 1 1995 64 69
60. G.C. Koomen, M.G. Betjes, D. Zemel Dialysate cancer antigen (CA) 125 is a reflection of peritoneal cell mass in CAPD patients Perit Dial Int 14 2 1994 132 136
61. M.M. Ho-dac-Pannekeet, J.K. Hiralall, D.G. Struijk Longitudinal follow-up of CA125 in peritoneal effluent Kidney Int 51 3 1997 888 893
62. A.M. Coester Early Diagnosis of Peritoneal Membrane Alterations [PhD thesis] 2010 University of Amsterdam Amsterdam, the Netherlands
63. T. Kishimoto The biology of interleukin-6 Blood 74 1 1989 1 10
64. C.A. Dinarello Cytokines: agents provocateurs in hemodialysis? Kidney Int 41 3 1992 683 694
65. R. Pecoits-Filho, P. Bárány, B. Lindholm, O. Heimbürger, P. Stenvinkel Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment Nephrol Dial Transplant 17 9 2002 1684 1688
66. K.H. Oh, J.Y. Jung, M.O. Yoon Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis Nephrol Dial Transplant 25 5 2010 1639 1646
67. M. Goldman, P. Vandenabeele, J. Moulart Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis Nephron 56 3 1990 277 280
68. D. Zemel, G.C.M. Koomen, A.A. Hart, I.J.M. ten Berge, D.G. Struijk, R.T. Krediet Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis J Lab Clin Med 122 6 1993 686 696
69. B.P. Giroir, J.H. Johnson, T. Brown, G.L. Allen, B. Beutler The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia J Clin Invest 90 3 1992 693 698
70. D.A. Lawrence Transforming growth factor-beta: an overview Kidney Int 47 suppl 47 1995 S19 S23
71. H.F. Dvorak, L.F. Brown, M. Detmar, A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 5 1995 1029 1039
72. Y. Tanaka, S. Katoh, S. Hori, M. Miura, H. Yamashita Vascular endothelial growth factor in diabetic retinopathy Lancet 349 9064 1997 1520
73. L.P. Aiello, R.L. Avery, P.G. Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 22 1994 1480 1487
74. T. Shimo, T. Nakanishi, T. Nishida Connective tissue growth factor induces proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo J Biochem 126 1 1999 137 145
75. J.W. Dobbie, K.W. Lloyd, C.A. Gall Categorization of ultrastructural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients Adv Perit Dial 6 1990 3 12
76. M.M. Ho-dac-Pannekeet, J.K. Hiralall, D.G. Struijk, R.T. Krediet Markers of mesothelial cells during treatment with peritoneal dialysis Adv Perit Dial 13 1997 17 22
77. C.Y. Le Poole, A.G. Welten, P.M. ter Wee A peritoneal dialysis regimen low in glucose degradation products results in increased cancer antigen 125 and peritoneal activation Perit Dial Int 32 3 2012 305 315
78. J. Graff, P. Joffe, S. Fugleberg, L.T. Jensen Collagen markers in peritoneal dialysis patients Adv Perit Dial 11 1995 24 27
79. G.E. Digenis, N.V. Dombros, E.V. Balaskas Procollagen-I and collagen-I in the serum and dialysate of CAPD patients: changes over time Perit DiaI Int 15 8 1995 371 374
80. P. Joffe, L.T. Jensen Type I and III procollagens in CAPD: markers of peritoneal fibrosis Adv Perit Dial 7 1991 158 160
81. M.M. Ho-dac-Pannekeet Assessment of Peritoneal Function and Mesothelial Cell Mass in Peritoneal Dialysis Patients [PhD thesis] 1997 University of Amsterdam Amsterdam, the Netherlands
82. G.J. Adema, F. Hartgers, R. Verstraten A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells Nature 387 1997 713 717
83. D.J. Loskutoff, M. Sawdey, J. Mimuro Type I plasminogen activator inhibitor Prog Hemost Thromb 9 1989 87 115
84. S. Dawson, A. Henney The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review Atherosclerosis 95 2-3 1992 105 117
85. L. Holmdahl, M. Falkenberg, M.L. Ivarsson, B.O. Risberg Plasminogen activators and inhibitors in peritoneal tissue APMIS 105 1 1997 25 30
86. B.C. Marshall, A. Santana, Q.P. Xu Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells J Clin Invest 91 4 1993 1792 1799
87. P.J. Margetts, P. Bonniaud, L. Liu Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum J Am Soc Nephrol 16 2 2005 425 436
88. P.Z. Khasigov, O.V. Podobed, S.A. Ktzoeva Matrix metalloproteinases of normal human tissues Biochemistry (Mosc) 66 2 2001 130 140
89. I.E. Collier, S.M. Wilhelm, A.Z. Eisen H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen J Biol Chem 263 14 1988 6579 6587
90. S.M. Wilhelm, I.E. Collier, B.L. Marmer, A.Z. Eisen, G.A. Grant, G.I. Goldberg SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages J Biol Chem 264 29 1989 17213 17221
91. I. Hirahara, M. Inoue, K. Okuda, Y. Ando, S. Muto, E. Kusano The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis - a multicentre study in Japan Nephrol Dial Transplant 22 2 2007 560 567
92. M. Cuccurullo, C. Evangelista, A. Vilasi Proteomic analysis of peritoneal fluid of patients treated by peritoneal dialysis: effect of glucose concentration Nephrol Dial Transplant 26 6 2011 1990 1999
93. R. Raaijmakers, W. Pluk, C.H. Schroder Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis Nephrol Dial Transplant 23 7 2008 2402 2405
94. W.T. Lin, C.C. Tsai, C.Y. Chen Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis Ren Fail 30 8 2008 772 777
95. H.Y. Wang, Y.F. Tian, C.C. Chien Differential proteomic characterization between normal peritoneal fluid and diabetic dialysate Nephrol Dial Transplant 25 6 2010 1955 1963
96. S. Sritippayawan, W. Chiajong, T. Semangoen Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes J Proteome Res 6 11 2007 4356 4362